AstraZeneca reports positive Phase III results for Imfinzi in small cell lung cancer
Despite a failed bid to expand Imfinzi’s treatment scope in NSCLC, the drug has proved effective in treating small cell lung cancer.
Despite a failed bid to expand Imfinzi’s treatment scope in NSCLC, the drug has proved effective in treating small cell lung cancer.
What's Your Reaction?
